Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Selection of women at risk for cervical cancer in an HIV-infected South African population.
Van Zummeren M, Kremer WW, Van Aardt MC, Breytenbach E, Richter KL, Rozendaal L, Witte BI, De Strooper LMA, Hesselink AT, Heideman DAM, Snijders PJF, Steenbergen RDM, Dreyer G, Meijer CJLM. Van Zummeren M, et al. Among authors: witte bi. AIDS. 2017 Sep 10;31(14):1945-1953. doi: 10.1097/QAD.0000000000001583. AIDS. 2017. PMID: 28692545
Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN.
Uijterwaal MH, van Zummeren M, Kocken M, Luttmer R, Berkhof J, Witte BI, van Baal WM, Graziosi GCM, Verheijen RHM, Helmerhorst TJM, van Dijken DKE, Spruijt JWM, van Kemenade FJ, Fransen-Daalmeijer N, Bekker-Lettink M, Heideman DAM, Snijders PJF, Steenbergen RDM, Meijer CJLM. Uijterwaal MH, et al. Among authors: witte bi. Gynecol Oncol. 2016 Oct;143(1):135-142. doi: 10.1016/j.ygyno.2016.07.089. Epub 2016 Jul 16. Gynecol Oncol. 2016. PMID: 27430395
Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.
Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJ, Heideman DA, Boon D, Koljenovic S, Baatenburg-de Jong RJ, Leemans CR. Rietbergen MM, et al. Among authors: witte bi. Ann Oncol. 2013 Nov;24(11):2740-5. doi: 10.1093/annonc/mdt319. Epub 2013 Aug 14. Ann Oncol. 2013. PMID: 23946330 Free article. Clinical Trial.
Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.
Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT, Witte BI, Baatenburg de Jong RJ, Meijer CJ, Snijders PJ, Brakenhoff RH. Rietbergen MM, et al. Among authors: witte bi. Int J Cancer. 2013 Apr 1;132(7):1565-71. doi: 10.1002/ijc.27821. Epub 2012 Nov 23. Int J Cancer. 2013. PMID: 22949073 Free article.
Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis.
Hubers AJ, Brinkman P, Boksem RJ, Rhodius RJ, Witte BI, Zwinderman AH, Heideman DA, Duin S, Koning R, Steenbergen RD, Snijders PJ, Smit EF, Sterk PJ, Thunnissen E. Hubers AJ, et al. Among authors: witte bi. J Clin Pathol. 2014 Aug;67(8):707-11. doi: 10.1136/jclinpath-2014-202414. Epub 2014 Jun 10. J Clin Pathol. 2014. PMID: 24915850
Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing.
Uijterwaal MH, Polman NJ, Van Kemenade FJ, Van Den Haselkamp S, Witte BI, Rijkaart D, Berkhof J, Snijders PJ, Meijer CJ. Uijterwaal MH, et al. Among authors: witte bi. Cancer Prev Res (Phila). 2015 Jun;8(6):502-8. doi: 10.1158/1940-6207.CAPR-14-0409. Epub 2015 Mar 16. Cancer Prev Res (Phila). 2015. PMID: 25776933
DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
Hubers AJ, Heideman DA, Duin S, Witte BI, de Koning HJ, Groen HJ, Prinsen CF, Bolijn AS, Wouters M, van der Meer SE, Steenbergen RD, Snijders PJ, Uyterlinde A, Berkhof H, Smit EF, Thunnissen E. Hubers AJ, et al. Among authors: witte bi. J Clin Pathol. 2017 Mar;70(3):250-254. doi: 10.1136/jclinpath-2016-203734. Epub 2016 Aug 5. J Clin Pathol. 2017. PMID: 27496969 Clinical Trial.
Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.
Polman NJ, Uijterwaal MH, Witte BI, Berkhof J, van Kemenade FJ, Spruijt JW, van Baal WM, Graziosi PG, van Dijken DK, Verheijen RH, Helmerhorst TJ, Steenbergen RD, Heideman DA, Ridder R, Snijders PJ, Meijer CJ. Polman NJ, et al. Among authors: witte bi. Int J Cancer. 2017 Jan 15;140(2):423-430. doi: 10.1002/ijc.30449. Epub 2016 Oct 11. Int J Cancer. 2017. PMID: 27677098 Free article.
Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study.
Uijterwaal MH, Witte BI, Van Kemenade FJ, Rijkaart D, Ridder R, Berkhof J, Balfoort-van der Meij GA, Bleeker MC, Snijders PJ, Meijer CJ. Uijterwaal MH, et al. Among authors: witte bi. Br J Cancer. 2014 Mar 18;110(6):1579-86. doi: 10.1038/bjc.2014.34. Epub 2014 Feb 11. Br J Cancer. 2014. PMID: 24518601 Free PMC article.
118 results